MIA researchers sharing the world stage at ESMO24
MIA’s leading experts and early career researchers have shared the world stage at the annual European Society for Medical Oncology (ESMO) Congress in Barcelona.
Preventing disease recurrence in BRAF positive melanoma patients
Final results of the COMBI-AD clinical trial, published in New England Journal of Medicine, show significant benefit in preventing disease progression in BRAF positive Stage III melanoma patients.
Australian researchers spearhead cancer treatment revolution
In what has been described as a cancer treatment revolution, the pre-surgery use of combination immunotherapy looks to become standard treatment for melanoma and impact other cancers across the globe.
Prof Georgina Long elected Fellow of Australian Academy of Science
Congratulations to Professor Georgina Long AO, elected as a Fellow of the Australian Academy of Science in recognition of her outstanding contribution to science.
An inspiring update from the 2024 Australians of the Year
Listen to Profs Long and Scolyer on ABC Radio Sydney for an update on Richard's #braincancer journey & recent results. how melanoma science is being used to treat his #glioblastoma. Budget funding news and their Australian of the Year activities.
PBS listing is life-changing news
The federal government has announced a new immunotherapy treatment for advanced melanoma patients has been added to PBS, significantly reducing the cost of the life-saving treatment.
Four MIA researchers receive Tour de Cure grants
We are delighted to have been successful in receiving four research grants recently awarded by Tour de Cure Australia.
NADINA trial “will shape medicine in 2024”
A clinical trial, developed by MIA researchers in collaboration with international colleagues, has been named by prestigious journal Nature Medicine as one of 11 clinical trials likely to have the most impact on global medicine in the year ahead.
Co-Medical Directors named in list of “News Makers of 2023”
Prof Georgina Long and Prof Richard Scolyer have been named in Top 52 News Makers for 2023 by the Sydney Morning Herald 'Good Weekend' magazine.
MIA researchers receive 2023 NSW Premier’s Awards
Congratulations to MIA’s Assoc Professor Alex Menzies and Rebecca Simpson, both very worthy recipients of 2023 NSW Premier’s Awards for Outstanding Cancer Research.